Facet Biotech competitors

Mr. Dennis M. Lanfear is a President and Chief Executive Officer at COHERUS BIOSCIENCES, INC. and is based in United States.

Vincent Milano joined Idera as Chief Executive Officer in December 2014. Mr. Milano most recently served as Chairman, President, and Chief Executive Officer of ViroPharma, which was acquired by Shire Pharmaceuticals in January 2014. Under his stewardship, ViroPharma became a leading developer of innovative therapies for rare diseases, with the approval and commercialization of its lead product, Cinryze, for the treatment of hereditary angioedema in the United States and Europe. Mr. Milano joined ViroPharma in 1996 and served as Vice President, Chief Financial Officer, and Treasurer from 1997 to 2006 before becoming Chief Executive Officer. He was instrumental in building the company, including leading efforts to raise nearly $900 million in capital, as well as acquisitions of Lev Pharmaceuticals and the drug Vancocin from Eli Lilly. In addition, he played critical roles in business development and investor relations activities for ViroPharma, and contributed significantly to establishing the strategic focus of the company. Prior to joining ViroPharma, he served as a senior manager at KPMG LLP, an independent registered public accounting firm.

Biotechnology executive with more than sixteen years of experience in business development for mid-sized and large biotechnology/pharmaceutical and healthcare companies. Key member of the Boehringer Ingelheim CMB Senior Leadership Team that sets strategic direction, and major contributor to management as a whole. Designing and implementing strategic business plans for US/Asia B2B services in the area of Life Sciences/Pharma. Experienced in building and leading high performance Sales / Business Development and Key Account teams, identifying new business opportunities and closing large business transactions. Extensive network and relationships with existing clients and industry contacts, proven track record of selling large, integrated offerings and extensive consultative sales experience. Spearheading large business development initiatives. Deep understanding of the Biotech/Pharma market: products and services, players, technologies, and a rolodex of contacts in related markets. Negotiation of in-licensing, research, development, and strategic manufacturing agreements as well as co-development agreements. Specialties: - Building and leading high performance teams in Asia and US - Strategic business planning and implementation - Managing and overseeing overall project acquisition/BD process - Cross cultural (Europe, US, Asia) and global leadership experience - Large USD value transactions for strategic B2B service agreements - Industry analysis, business strategy development, business plans and execution - Strong scientific background in Chemistry, Biology and Pharma